National case definition: Rubella

Date of last revision/review: May 2008

National reporting

Only confirmed cases of disease should be notified.

Type of surveillance

Active, weekly case-by-case notification (including zero-notification) by provincial and territorial ministries of health to the Canadian Measles/Rubella Surveillance System (CMRSS)

Case classification

Confirmed case

Laboratory confirmation of infection in the absence of recent immunization (see Clinical evidence section) with rubella‑containing vaccine:

Probable case

Clinical illness

Laboratory comments

Clinical evidence

Clinical illness is characterized by fever and rash, and at least one of the following:

The most frequent reaction to measles-mumps-rubella (MMR) immunization is malaise and fever (with or without rash) occurring 7-12 days after immunization. However, this should be determined for each case, as these reactions and time frames can vary (Canadian Immunization Guide, 7th edition).

ICD code(s)

ICD-10 code(s)

ICD-9/ICD-9CM code(s)

Type of international reporting

Weekly reporting to the Pan American Health Organization, in accordance with the goal of eliminating rubella and congenital rubella syndrome in the Western Hemisphere.

Comments

Probable case definitions are provided as guidelines to assist with case finding and public health management, and are not for national notification purposes.

Active weekly surveillance began in 2006. All cases are reviewed by the Immunization and Respiratory Infections Division (Public Health Agency of Canada) for classification before being added to the national database.

References

Previous case definitions

Page details

2019-11-22